<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Memantine, an uncompetitive <z:chebi fb="0" ids="31882">NMDA</z:chebi> open-channel blocker, has been shown to be effective in preventing neuronal damage after permanent focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Reperfusion after a long period of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> may aggravate the progression of neuronal damage </plain></SENT>
<SENT sid="2" pm="."><plain>Those drugs that show protective effects after permanent <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, therefore, might fail to do so against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion injury </plain></SENT>
<SENT sid="3" pm="."><plain>In this study we evaluated the effects of memantine on <z:hpo ids='HP_0002181'>brain edema</z:hpo> formation and ischemic injury volume after transient <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Male Spontaneously Hypertensive Rats (SHR) weighing 250-300 g were anesthetized with <z:chebi fb="2" ids="5615">halothane</z:chebi> and subjected to 1 hour of temporary middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> by an intraluminal suture </plain></SENT>
<SENT sid="5" pm="."><plain>20 mg/kg of memantine or saline were injected intraperitoneally 5 min. after the induction of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Physiological parameters and regional cerebral blood flow were monitored during the surgical procedure </plain></SENT>
<SENT sid="7" pm="."><plain>Brain water content and ischemic injury volume were measured with the wet dry method and 2,3,5-triphenyl tetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> monohydrate (TTC) staining, respectively, at 24 hours after occlusion </plain></SENT>
<SENT sid="8" pm="."><plain>There were no statistically significant differences between the groups regarding physiological parameters during the procedure </plain></SENT>
<SENT sid="9" pm="."><plain>Memantine treatment (n=9) reduced the brain water content significantly in the cortex compared to saline treatment (n=8; 83 </plain></SENT>
<SENT sid="10" pm="."><plain>1+/-0.7% vs. 84.5+/-1.5%, respectively, p&lt;0.05) </plain></SENT>
<SENT sid="11" pm="."><plain>The total volume of ischemic brain injury was 300+/-49 mm(3) in the animals treated with saline (n=13) </plain></SENT>
<SENT sid="12" pm="."><plain>Treatment with 20 mg/kg memantine (n=14) reduced the ischemic injury volume to 233+/-61 mm(3) (P&lt;0.01) </plain></SENT>
<SENT sid="13" pm="."><plain>These results demonstrate that the harmful effects of recirculation after a period of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> can be attenuated by the treatment of memantine, perhaps by its action at the <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors </plain></SENT>
</text></document>